APA (7th ed.) Citation

K, M., JD, C., PR, B., CL, D., A, D. S., D, M., . . . N, H. (2026). Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial. Respiratory investigation, 64(2), 101357. https://doi.org/10.1016/j.resinv.2025.101357

Chicago Style (17th ed.) Citation

K, Morimoto, et al. "Efficacy and Safety of Brensocatib in Japanese Patients with Non-cystic Fibrosis Bronchiectasis: Analysis of the ASPEN Trial." Respiratory Investigation 64, no. 2 (2026): 101357. https://doi.org/10.1016/j.resinv.2025.101357.

MLA (9th ed.) Citation

K, Morimoto, et al. "Efficacy and Safety of Brensocatib in Japanese Patients with Non-cystic Fibrosis Bronchiectasis: Analysis of the ASPEN Trial." Respiratory Investigation, vol. 64, no. 2, 2026, p. 101357, https://doi.org/10.1016/j.resinv.2025.101357.